Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.thechemopharmalaboratoriesltd.com | |
Market Cap | 5.99 Cr. | |
Enterprise Value(EV) | 0.40 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.23 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 17.87 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 32.17 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 78.33 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 0.51 | Calculated using Price: 39.90 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.15 Cr. | 1,500,000 Shares |
FaceValue | 10 | |
Company Profile | ||
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues. |
1 Day |
|
+5.00% |
1 Week |
|
+5.00% |
1 Month |
|
+7.69% |
3 Month |
|
-0.50% |
6 Month |
|
+14.00% |
1 Year |
|
-3.39% |
2 Year |
|
+123.53% |
5 Year |
|
-2.09% |
10 Year |
|
+121.67% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 5.10 | 5.61 | 4.15 | 60.99 | 1.00 | 2.02 | 3.94 | 2.30 | 4.97 | |
Return on Capital Employed (%) | 6.22 | 7.52 | 5.96 | 68.41 | 7.54 | 2.50 | 4.69 | 2.86 | 3.24 | |
Return on Assets (%) | 4.79 | 5.20 | 3.90 | 57.64 | 0.96 | 2.00 | 3.88 | 2.27 | 4.99 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 5 | 5 | 5 | 10 | 10 | 10 | 11 | 11 | 12 | 12 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Curr. Liab. | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 6 | 6 | 11 | 10 | 10 | 11 | 11 | 11 | 11 | |
Non Curr. Assets | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 0 | 5 | 6 | |
Curr. Assets | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 11 | 6 | 6 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 6 | 6 | 11 | 10 | 10 | 11 | 11 | 11 | 11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | |||||||||||
Other Income | 0 | 1 | 0 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Income | 0 | 1 | 0 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | |
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | |||||||
Taxation | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 0 | |
Adjusted EPS | 2 | 2 | 1 | 31 | 1 | 1 | 3 | 2 | 4 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 6 | -2 | -5 | 5 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | |
Cash Fr. Finan. | -1 | 1 | 2 | -2 | |||||||
Net Change | 0 | 0 | 0 | 0 | 6 | 1 | -5 | 6 | 1 | -1 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 7 | 8 | 3 | 9 | 2 | 1 |
Wed, 29 Mar 2023
Closure of Trading Window Intimation of Trading Window Closure |
Fri, 24 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement) Regulation 2015 |
Tue, 28 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement) Regulation 2015 |
Wed, 29 Mar 2023 |
|
|
|
|
|